2020-12-31-accounts - Pancreatic Cancer Action

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

Trustees				H Matthews
				N Menezes
				N Mumford
				S Krag
				H Goodfellow
				L Condron
				D Georgiou
				R Legg		(Appointed	16 March 2020)
				C Carter		(Appointed	1 April 2020)
				E Cowan		(Appointed	24August 2021)
				N Longworth		(Appointed	27August 2021)
				L Nylander		(Appointed	24August 2021)
Secretary				G Brown
Charity number		(England	and Wales)	1137689
Charity number		(Scotland)		SC049777
Company	number			07272699
Registered	office			Unit 9
				Oakhanger	Farm	Business Park
				Oakhanger	Road
				Oakhanger
				Hampshire
				GU35 9JA
Auditor				Alliotts LLP
				Friary Court
				13-21 High	Street
				Guildford
				Surrey
				GU1 3DL

		Page
CEO's Report		1-2
Trustees' report		3-15
Statement ofTrustees'	responsibilities	16
Independent auditor's	report	17-20
Statement offinancial	activities	21
Balance sheet		22
Statement ofcash flows
Notes to the financial	statements	24-37

Our mission	Our mission	Our mission
Our mission is to improve survival rates			of pancreatic cancer		by ensuring		more people are				diagnosed			early
and that everyone	has access to effective		treatments, support,		information		and	care.
Objectives
The charity's objectives are:
A	Awareness	- increase	public	awareness	and	knowledge		of pancreatic			cancer		and		its
symptoms	to achieve	early diagnosis
C	Campaign	and lobby	the government and		key	stakeholders		for	change		to advance				the
standard	of healthcare	for individuals affected by pancreatic				cancer
T	Train and	provide pioneering		educational	resources		for	our	medical		and	healthcare
communities
I	Innovative	research -	we fund	it, we support it		- to improve		early diagnosis				and	develop
effective 0	treatments to improve pancreatic Offer the provision of practical			cancer outcomes and emotional support			and	information		to all		affected			by
pancreatic cancer
N	Now- we are the action charity			and action is needed more than ever before!

		Unrestricted	Restricted	Total	Unrestricted	Restricted	Total
		funds	funds		funds	funds
	Notes	2020	2020 f	2020 F	2019 F	2019f	2019 F
Income from:
Donations and legacies		532,104	623,639	1,155,743	734,707	12,345	747,052
Charitable activities			92,236	92,236	1,300	25,500	26,800
Other trading activities		7,697		7,697	11,179		11,179
Investments		801		801	1,474		1,474
Total income		540,602	715,875	1,256,477	748,660	37,845	786,505
Ex enditure on:
Raising funds		270,766	37,849	308,615	292,879		292,879
Charitable activities		312,399	125,439	437,838	513,135	95,796	608,931
Total resources
expended		583,165	163,288	746,453	806,014	95,796	901,810
Net (expenditure)/income
for the year/
Net movement in funds		(42,563)	552,587	510,024	(57,354)	(57,951)	(115,305)
Fund balances at 1
January 2020		351,966	67,947	419,913	409,320	125,898	535,218
Fund balances at 31
December 2020		309,403	620,534	929,937	351,966	67,947	419,913

			2020		2019
		Notes	F		F
Fixed assets
Tangible assets		13		18,571		34,086
Current assets
Stocks		14	14,892		29,456
Debtors falling due	after one year	15			12,990
Debtors falling due	within one year	15	113,325		71,349
Cash at bank and	in hand		840,651		306,960
			968,868		420,755
Creditors: amounts falling due within
one year		16	(57,502)		(34,928)
Net current assets				911,366		385,827
Total assets less	current liabilities			929,937		419,913
Income funds
Restricted funds		18		620,534		67,947
Unrestricted funds
Designated funds		20	15,485		17,107
General unrestricted funds			293,918		334,859
				309,403		351,966
				929,937		419,913

							2019
				Notes			F
Cash flows from operating		activities
Cash generated from/(absorbed			by)	25
operations						532,890		(119,330)
Investing	activities
Purchase	oftangible fixed assets						(4,599)
Investment	income received				801		1,474
Net cash	generated from/(used		in)
investing	activities					801		(3,125)
Net cash	used in financing	activities
Net increase/(decrease) in		cash and		cash
equivalents						533,691		(122,455)
Cash and	cash equivalents	at beginning		ofyear		306,960		429,415
Cash and	cash equivalents	at end of		year		840,650		306,960

			Unrestricted	Restricted	Total	Unrestricted	Restricted	Total
			funds	funds		funds	funds
						as restated
			2020	2020		2019	2019	2019
Donations	and gifts		501,104	623,639	1,124,743	707,221	12,345	719,566
Grants receivable for
core activities			31,000		31,000	6,878		6,878
Donated	goods and
services						20,608		20,608
			532,104	623,639	1,155,743	734,707	12,345	747,052
Charitable		activities
					Grants	Grants	Other	Total
								2019
					2020	2019	2019
					F	F	F
Performance		related	grants		33,455	25,500		25,500
Government		Grant			58,781
Other income							1,300	1,300
					92,236	25,500	1,300	26,800
Analysis	by	fund
Unrestricted		funds					1,300	1,300
Restricted	funds				92,236	25,500		25,500

Unrestricted	Unrestricted
funds	funds
	as restated
	2019
7,697	11,179

		Unrestricted	Unrestricted
		funds	funds
		2020	2019
Interest	receivable	801	1,474

			Unrestricted	Restricted	Total	Unrestricted
			funds	funds		funds
			2020	2020	2020	2019
Fundraisin	and	ublici
Advertising			2,508		2,508	2,892
Other fundraising		costs	44,265		44,265	85,631
Staff costs			165,990	37,849	203,839	147,998
Depreciation	and	impairment	5,096		5,096	4,824
Support costs			37,103		37,103	41,266
Fundraising	and	publicity	254,962	37,849	292,811	282,611
TTradin t costs
Other trading	activities		15,804		15,804	10,268
			270,766	37,849	308,615	292,879

				Raising	Supporting	Medical	Patient	Total	Total
				awareness	research	education	support/	2020	2019
							information
						2020	2020
						F	F
Staff costs				133,330	39,581	18,624	39,759	231,294	319,279
Depreciation		and
impairment				5,982	1,817	836	1,784	10,419	10,406
Other costs				67,989	21,418	9,848	21,024	120,279	217,516
				207,301	62,816	29,308	62,567	361,992	547,201
Share ofsupport costs
(see note	9)			34,428	10,459	4,809	10,267	59,963	51,239
Share ofgovernance			costs
(see note	9)			9,119	2,770	1,274	2,720	15,883	10,491
				250,848	76,045	35,391	75,554	437,838	608,931
Analysis	by	fund
Unrestricted		funds		181,974	52,981	26,558	50,886	312,399	513,135
Restricted	funds			68,874	23,064	8,833	24,668	125,439	95,796
				250,848	76,045	35,391	75,554	437,838	608,931

				Raising	Supporting	Medical	Patient	Total
				awareness	research	education	support/	2019
							information
				F	F	F	F
Staff costs				172,223	85,142	53,272	8,642	319,279
Depreciation		and impairment		5,613	2,775	1,736	282	10,406
Other costs				114,989	56,185	41,982	4,360	217,516
				292,825	144,102	96,990	13,284	547,201
Share of	support costs (see note 9)			27,639	13,664	8,549	1,387	51,239
Share of	governance		costs (see note 9)
				5,660	2,797	1,750	284	10,491
				326,124	160,563	107,289	14,955	608,931
Analysis	by	fund
Unrestricted		funds		237,669	155,563	107,289	12,614	513,135
Restricted	funds			88,455	5,000		2,341	95,796
				326,124	160,563	107,289	14,955	608,931

Support	cost	s
				Support	Governance	2020	Support	Governance	2019
				costs	costs		costs	costs
							F
Rent				48,062		48,062	42,214		42,214
Office costs				3,076		3,076	7,253		7,253
Telephone	costs			6,589		6,589	5,925		5,925
Computer	costs			21,609		21,609	16,347		16,347
Insurance				3,758		3,758	383		383
Training,	recruitment		and
internship	costs			1,988		1,988	10,416		10,416
Book-keeping		and
Accountancy				1,747		1,747	1,687		1,687
Bank charges				2,468		2,471	3,418		3,418
Audit fees					6,960	6,960		3,288	3,288
Legal and	professional				16,692	16,692		12,065	12,065
				89,297	23,652	112,952	87,643	15,353	102,996
Analysed	between
Fundraising				29,334	7,769	37,103	36,404	4,862	41,266
Charitable	activities			59,963	15,883	75,846	51,239	10,491	61,730
				89,297	23,652	112,949	87,643	15,353	102,996

Employees		(Continued)
Employment costs	2020	2019
	F	F
Wages and salaries	392,647	421,215
Social security costs	31,655	37,483
Other pension costs	10,831	8,579
	435,133	467,277

more we	re:
		2020	2019
		Number	Number
F60,000	- F70,000		1

Tangible fixed assets
		Fixtures,	Computers	Total
		fittings &
		equipment
Cost
At 1 January 2020		31,237	41,911	73,148
At 31 December 2020		31,237	41,911	73,148
Depreciation and impairment
At 1 January 2020		15,123	23,939	39,062
Depreciation charged	in the year	7,255	8,260	15,515
At 31 December 2020		22,378	32,199	54,577
Carrying amount
At 31 December 2020		8,859	9,712	18,571
At 31 December 2019		16,114	17,972	34,086

14	Stocks
				2020	2019
				F	F
	Finished goods and goods for resale			14,892	29,456
15	Debtors
				2020	2019
	Amounts falling due		within one year:
	Other debtors			278	178
	Prepayments	and accrued income		113,047	71,171
				113,325	71,349
				2020	2019
	Amounts falling due		after more than one year:
	Prepayments	and accrued income			12,990
	Total debtors			113,325	84,339
16	Creditors: amounts		falling due within one year
				2020	2019
	Other taxation	and social security		30,432	12,046
	Trade creditors			(6)	19,136
	Accruals and	deferred	income	27,076	3,746
				57,502	34,928

			Movement	in funds			Movement	in funds
		Balance at	Incoming	Resources	Balance at		Incoming	Resources	Balance at
		1 January 2019	resources	expended1	January	2020	resources	expended	31 December
									2020
Pat 8 Paul		8,769	897	(9,666)			1,366		1,366
Early
diagnosis
challenge
award
(research)			5,000	(5,000)
POW app		17,200			17,200				17,200
Recipe Book		22,451		(2,341)	20,110				20,110
Noel		41,784		(41,784)
Patient
Information
Booklets		31,724		(4,587)	27,137			(9,150)	17,987
Awards for	all	3,670		(3,670)
Hope is
Contagious		300	190	(490)			6		6
NIPanC			13,258	(13,258)			14,706	(8,250)	6,456
PCAware	Nl		15,000	(15,000)
PCAware
Wales			3,500			3,500	24,245		27,745
Hard to reach
gr'oups							6,000		6,000
Pancreatic
Cancer
Scotland							607,560	(87,106)	520,454
HMRC JRS
Grant							58,782	(58,782)
Health
information
officer							2,250		2,250
Community
volunteers							960		960
		125,898	37,845	(95,796)	67,947		715,875	(163,288)	620,534

Analysis of net assets	between funds
	Unrestricted	Restricted	Total	Unrestricted	Restricted	Total
	2020	2020	2020	2019	2019	2019
	F	F	F	F	F	F
Fund balances at 31
December 2020 are
represented by:
Tangible assets	18,571		18,571	34,086		34,086
Current assets/
(liabilities)	290,832	620,534	911,366	317,880	67,947	385,827
	309,403	620,534	929,937	351,966	67,947	419,913

The income	funds	funds	of the	charity	include	the following	designated	funds	which	which	have	been set	aside out of
unrestricted	funds		by the	trustees	for specific purposes:
						Movement	in funds
				Balance at		Incoming	Resources		Balance		at	Resources	Balance at
				1 January 2019		resources	expended1	January		2020		expended	31 December
													2020
													F
Early diagnosis		challenge
award (research)					73,292		(56,185)		17,107			(1,622)	15,485
Core costs						8,878	(8,878)
					73,292	8,878	(65,063)		17,107			(1,622)	15,485

										2020	2019
										F	F
	Aggregate compensation									42,512	68,890
	The key management	personnel	ofthe		Charity		is considered		to be the CEO.
	There were no other related party			transactions.
25	Cash generated from	operations								2020	2019
										F	F
	Surplus/(deficit) for the	year								510,024	(115,305)
	Adjustments for:
	Investment income recognised		in	statement		offinancial		activities		(801)	(1,474)
	Depreciation and impairment oftangible				fixed assets					15,515	15,230
	Movements in working	capital:
	Decrease/(increase) in	stocks								14,564	(872)
	(Increase) in debtors									(28,986)	(7,049)
	Increase/(decrease) in	creditors								22,574	(9,860)
	Cash generated from/(absorbed			by) operations						532,890	(119,330)